Abstract
Along tract statistics enables white matter characterization using various diffusion MRI (dMRI) metrics. Here, we applied a machine learning (ML) method to assess the clinical utility of dMRI metrics along corticospinal tracts (CST), investigating whether motor glioma patients can be classified with respect to their motor status. The ML-based analysis included developing models based on support vector machine (SVM) using histogram-based measures of dMRI-based tract profiles (e.g., mean, standard deviation, kurtosis and skewness), following a recursive feature elimination (RFE) method based on SVM (SVM-RFE). Our model achieved high performance (74% sensitivity, 75% specificity, 74% overall accuracy and 77% AUC). Incorporating the patients’ demographics and clinical features such as age, tumor WHO grade, tumor location, gender and resting motor threshold (RMT) into our designed models demonstrated that these features were not as effective as microstructural measures. The results revealed that ADC, FA and RD contributed more than other features to the model.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Deutsche Forschungsgemeinschaft German Research Foundation (DFG) under Germany ́s Excellence Strategy-EXC 2025-390648296.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study proposal is in accordance with ethical standards of the Declaration of Helsinki and was approved by the Ethics Commission of the Charite University Hospital (#EA1/016/19). All patients provided written informed consent for medical evaluations and treatments within the scope of the study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos